Document 4a6kzezM2bnejJmVo3BbZ6QGx
3M intemal Correspondence
TO: FROM: SUBJECT: DATE:
SM. LEAHY - EXECUTIVE-220-13E:33 CW. OLSON - CF&AP GROUP COMPLIANCE - 236.GL-04 Fluorochemical Steering Committee Minutes July 22, 1982
`UTphoenFltuhoerroechceommimceanldaSttieeorniongtChoemmJiultyte1e6 cmeotmuilyte21m,e1e9t9i2n.g nAewcompeymobferthseaadgdeenddaweisreatCaacrhoeld. MBryosl,eGtreotuopyGenooerfaJluunCeoun5,se1l9,9a2,ndwDitohnrTehsepiescsnt,hDeirreecctoomrm,eCnodrpaotriaotnes Pfrroodmutchte RFesCpSonCsMibailyity. 26, 1992 meeting were reviewed. `Trheceopmumrepnodsaetoifotnhsisfomreefuttiunrge awcatsitonos.updGauteestsheprFeCsSeCnoinnclcuudreednDtr.issFureasnaknGditlolidleavndelaonpd Dr. Jeff M`aWnoldteer,fJriommJOochcnuspoant,ioannadlRMoebdeizctiHnoe,weDlrl. fCr.omD.EHnvoidrgosnomne,ntCaolrpEonrgaintceeMreidnigcaaaldDiRroegcetrorB,erJkiimns, Toxicology. `thTahteafgorlleoawidnegalsuomfamcartiievsiwtieysreocpcruesreinntgedo.utsRiodgee3rMPoernkinfsl,uoCroocrhpeomriactaelsT.oTxhiceorleohgyavpeabineteedno3u2t `ppeubrlifclatuiooonnrspoercfalavcorirdbowdoiectxahtytohnleirciaactci,Td.heTrheeysaadsdoitcointaedlwadodriktoonnalpweorrkfolnuorooaccidobneiineg hraesposretnetdusin ttohxeicliittyedraatturaet. hTyhhiaswvoeudelvdebleoppeerdtoinntenet tio osuufruFrCa-m1i4d3.Tshtuidsiedsi. dGnroitfcfinoCnhetmainciyals wthoeryeeias rmostruediteosx.iciTthyeiyn dsiod,mehoawqeuavteirc,sspeucbimesiatin "bFroarnYchoeudrfIlnufoorromcahteimoinc"alinthwahniscthriitghatppcehaarisn material. Dinrf.oFrrmaantkioGnilolnilaannde,pi&decmoinolsouglicts0tutdhyeocncCuhpeamtoilointazleMmepdliocyienseD.epIatrwtamsenpotpinrteesdeonuttetdhat in ohcocrumro.raRlessutlutdsiesshsouwcehdatshtahitshmeecaosnutrraobllgercohuapnsgehsowdeodmnort enebceisosoardilfylumoerianne tthhaatndwiseeawsoeuwlidllhave iexmppercotpeedr. se"lTehicstmioanyobfethbeeccoaunsteoolfgaronuup.nknChoawnngeexspionsutersetoorstceoruonledhwaerveebaegeenacndauwseeidgbhtyrelated
2725.0001
"Tal Exhibit 3214 MAD0838323 pEuxhsibit 3M_MN00000789
S. M. Leahy PJaulgye222, 1992
`Adecatohhowratsmloerstsaltihtaty tshteudgyenwehriaclhposphuolwaetidonn.o eTxhciesssmamoyrihaalvietybeweansbreepcoarutseed.ofInloowthienrciwdoerndcse,of lcaorodkieodvaastctuhlearvadliuseeoasfes3..0Wwhaesnhtihgehelrentghtahnoefxpseecrtviecdebvuetrssuislpnrootstsriagtneifciacnacnte.r m7o4r4tawloirtkyewrasswere studied and no major morality excesses were present.
arJiembeJionhngsopnr,imEarEil&yPloCokLaebdoarta.torNye,garteipvoertieodnotnhetrhmeaalnaslpyrtaiycahlaswobrekentousdaetde.andFhCe-i9s5aabndlFteoC-143 bdeotveicntelseveerlusmatobSiOaipnpedmtiondweavteelrooprspaickryeodnistaimlpel.e rLeafcetraetnicnegs.goaAtdsdihtaivoenableeenqudiopsmeedntanids oalnsoorder `and work is planned.
l`aRboogreartPoerireksiwnse,aTroexiucsoilnoggGyoSoerdviLcaebso,rarteoproyrtPerdactthiacteos.nBweocrakuswee ohuarvewodornkewiblyloruetqsuiidree extensive review the questionof GLP procedures for 3M internal laboratory procedures was discussed.
mFeomlbloewrisnagntdheDgre.neHroadlgmseoentiwnagsa
separate meeting of held. The principal
dfilsucoursoscihoenmciecnatlesrteederairnogucnodmtmhietcireeeation
of
a`tTehcehfnoilclaolwisnugb-sucbojmemcittstweeer1e0cpornosviiddeeregduifdoarnrceevfioerwtbhye sttheeertiencghncicoamlmistutb-eceoomnmittetcehen.ical maters.
Prioritize potential applications forriskandthecompounds related to them.
Relationship between exposure and blood skin versus the other types.
fluorine levels.
This would include the
Sampling and analytical exposure sampling techniques and recommendations for methods to be used.
A common approach to safety, health and environmental issues.
Collection and sharingoftechnical information related to safety, health and environmental issues and fluorochemicals.
Collection and sharing fluorochemicals.
of
safety,
health
and
environmental
information
related
to
Research directions for new fluorochemical materials.
Basic pharmacogetic metabolism studies.
2725.0002
aMA00638324 3M_MNO000O790
S. M. Leahy JPualgye232, 1992
AInitdiiaslcumsesmibonerfsoltloobweedcownhsiicdherceedntienrcelduaderdouRnodgethrePmeermkibnesrsfhriopm oTfoxtihicsoltoegchyn,icSatlancoSmomrietntseoen, fErEo&mPICn,dusDtrrsi.alJeHfyfgiMeanned,elJiamndJoFhrnasnoknGfirlolimltahndeEfrEo&mPOCccuLpaabtoiroantoarlyM,eRdiocbienret,HoDrw.elVl.s ffrroomm SAnAal&ytCiDcalAnSaelryvtiicceasl aLnabdorcahtaoirriiensg,thDeocnomJmaimtetseoer, JCroahingMBaurrhteovnkfarofmrotmheCeFnlturoarlocRheesmeiacraclh `Technology Center. `The following actions will be taken: 1. JAiumorJoochhnesmoincawlisl.l continue hisworkon the development of analytical capabilities for 2. TOlhseoFnlwuiolrloccahlelmtihcealfirTsetcmheneotliongg.y Sub-committee will be named by consensus and Craig 3. JwhoehtnhBeurtetnhheoafft,aLparrersyenZtoecdbbely,DrR.icGkilDlaivliasndacnodnsGteioturtjeesa2n TAdSaCmAs8w(ci)lscuobmnivsesnieont.o..determine 4. aTdhdereFslsuotrhoecchuermriecnatlprSitoereirtiynigssCuoems.mittee wil be reconvened as soon as appropriate to
2
de: Dale Bacon Robert Bringer
23E09 212807
Carol Bros John Buterhoff
222002-61.10E203
JFirmanJkohGnilsloinland
2202602 238.09
Jeif Mandel Roger Perkins
2220022660022
JTiommSuSgagve.reide, 223062-8180221
DFroannkThVeiiksisnegnstad ~~ 222235-3INN--0028
Larry Zosbel
2202E02
2725.0003
3MA00636325 3M_MN00O0O7S1